ArticleJournal of medical virology2022
The severity of the first 207 infections with the SARS-CoV-2 Omicron BA.2 variant, in Marseille, France, December 2021-February 2022.
Article in Journal of medical virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis.BMJ global health · 2023Pooled it
- Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England.BMC infectious diseases · 2024Article
- SARS-CoV-2 Viral Replication Persists in the Human Lung for Several Weeks after Symptom Onset.American journal of respiratory and critical care medicine · 2024Article
- Pre-Hospital Management of Patients with COVID-19 and the Impact on Hospitalization.Medicina (Kaunas, Lithuania) · 2023Article
- Viral load of SARS-CoV-2 Omicron is not high despite its high infectivity.Journal of medical virology · 2022Article
- Risk Factors Associated with Mortality in Hospitalized Patients with COVID-19 during the Omicron Wave in Brazil.Bioengineering (Basel, Switzerland) · 2022Article
- Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England.Nature communications · 2022Article
- Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.JAMA network open · 2022Article
- High rate of reinfection with the SARS-CoV-2 Omicron variant.The Journal of infection · 2022Article
- Current vaccine strategies against SARS-CoV-2: Promises and challenges.The Journal of allergy and clinical immunology · 2022Review
- Omicron BA.2 Lineage, the "Stealth" Variant: Is It Truly a Silent Epidemic? A Literature Review.International journal of molecular sciences · 2022Review
- Circulating Dynamics of SARS-CoV-2 Variants between April 2021 and February 2022 in Turkey.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022Article
- The emergence of SARS-CoV-2 Omicron subvariants: current situation and future trends.Le infezioni in medicina · 2022Review
- Case Report: The Experience of Managing a Moderate ARDS Caused by SARS-CoV-2 Omicron BA.2 Variant in Chongqing, China: Can We Do Better?Frontiers in medicine · 2022Article
- SARS-CoV-2 and COVID-19: A Narrative Review.British journal of biomedical science · 2022Review
- As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?Frontiers in public health · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.